...
首页> 外文期刊>Biomedical materials >Accelerated in vitro recellularization of decellularized porcine pericardium for cardiovascular grafts
【24h】

Accelerated in vitro recellularization of decellularized porcine pericardium for cardiovascular grafts

机译:用于心血管移植物的脱细胞猪心包的体外透填

获取原文
获取原文并翻译 | 示例
           

摘要

An ideal decellularized allogenic or xenogeneic cardiovascular graft should be capable of preventing thrombus formation after implantation. The antithrombogenicity of the graft is ensured by a confluent endothelial cell layer formed on its surface. Later repopulation and remodeling of the scaffold by the patient's cells should result in the formation of living autologous tissue. In the work presented here, decellularized porcine pericardium scaffolds were modified by growing a fibrin mesh on the surface and inside the scaffolds, and by attaching heparin and human vascular endothelial growth factor (VEGF) to this mesh. Then the scaffolds were seeded with human adipose tissue-derived stem cells (ASCs). While the ASCs grew only on the surface of the decellularized pericardium, the fibrin-modified scaffolds were entirely repopulated in 28 d, and the scaffolds modified with fibrin, heparin and VEGF were already repopulated within 6 d. Label free mass spectrometry revealed fibronectin, collagens, and other extracellular matrix proteins produced by ASCs during recellularization. Thin layers of human umbilical endothelial cells were formed within 4 d after the cells were seeded on the surfaces of the scaffold, which had previously been seeded with ASCs. The results indicate that an artificial tissue prepared by in vitro recellularization and remodeling of decellularized non-autologous pericardium with autologous ASCs seems to be a promising candidate for cardiovascular grafts capable of accelerating in situ endothelialization. ASCs resemble the valve interstitial cells present in heart valves. An advantage of this approach is that ASCs can easily be collected from the patient by liposuction.
机译:理想的脱细胞的同种异体或异种心血管移植物应能够在植入后预防血栓形成。通过形成在其表面上的汇合内皮细胞层确保移植物的抗诱导性。患者细胞的后来重新掺杂和重塑支架应导致形成活体组织。在这里提出的工作中,通过在表面和支架内部生长纤维蛋白网,并通过将肝素和人血管内皮生长因子(VEGF)连接到该网眼的纤维蛋白网。然后用人脂肪组织衍生的干细胞(ASCS)接种支架。虽然ASCS仅在脱细胞化心包的表面上生长,但纤维蛋白改性的支架完全被重新灌注在28d中,并且用纤维蛋白改性的支架,肝素和VEGF改性的支架已经在6天内重新灌注。标签自由质谱显示通过升高期间通过ASCS产生的纤连蛋白,胶原蛋白和其他细胞外基质蛋白。在将细胞接种在支架的表面上,在支架的表面上形成薄层的人脐细胞内形成薄层,其先前已用ASCS接种。结果表明,通过体外透腔制备的人工组织,具有自体ASC的脱细胞化非自体心包的重塑,似乎是能够加速原位内皮化的心血管移植物的有希望的候选者。 ASC类似于心脏瓣膜中存在的瓣膜间质细胞。这种方法的一个优点是通过吸脂来容易地从患者收集ASC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号